UniProtKB/SwissProt variant VAR

Variant information

Variant position:

200

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

US

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Alanine (A) to Glycine (G) at position 200 (A200G, p.Ala200Gly).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from small size and hydrophobic (A) to glycine (G)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

0

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

Found in patient with lung cancer; unknown pathological significance.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs199905033 [ dbSNP | Ensembl ]

Sequence information

Variant position:

200

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

918

The length of the canonical sequence.

Location on the sequence:

TSCTVDYSTVYFVNIEVWVE A ENALGKVTSDHINFDPVYKV

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TSCTVDYSTVYFVNIEVWVEAENALGKVTSDHINFDPVYKV

Mouse                         -SCMVSYMPTYYVNIEVWVEAENALGKVSSESINFDPVDKV

Rat                           SSCMMGYTPIYFVNIEVWVEAENALGNVSSEPINFDPVDKV

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	23 – 918	Interleukin-6 receptor subunit beta
Topological domain	23 – 619	Extracellular
Domain	125 – 216	Fibronectin type-III 1
Mutagenesis	189 – 189	V -> G. Does not induce ligand-independent activation.
Mutagenesis	190 – 190	Y -> G. Does not induce ligand-independent activation.
Mutagenesis	215 – 215	D -> G. Induces ligand-independent activation.
Beta strand	194 – 202

Literature citations

Low incidence of IL6ST (gp130) mutations in exon 6 in lung cancer of a Chinese cohort.
Sun L.; Sui L.; Cong X.; Ma K.; Ma X.; Huang Y.; Fan C.; Fu X.; Ma K.;
Cancer Genet. 207:291-298(2014)
Cited for: VARIANT GLY-200;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P40189: Variant p.Ala200Gly